Fentanyl Use Declines but Heroin and Methamphetamine Use Rise
Recent findings indicate a notable decline in fentanyl use, as highlighted in the latest signals report from Millennium Health. This report reveals a substantial shift in the landscape of drug use, showcasing an intriguing trend where, despite the drop in fentanyl detection, the use of alternative substances, particularly heroin and methamphetamine, has surged.
Analyzing Drug Testing Results
The analysis covers more than 1.4 million urine drug tests, with startling statistics drawing attention. It reports that approximately 93% of the population that tested positive for fentanyl also revealed the presence of other substances. This represents an increase in polysubstance use, specifically a 14% rise in stimulant usage compared to the prior year.
The Emergence of Stimulant Use in Fentanyl Positives
Critically, the data suggests that nearly 60% of fatal fentanyl overdoses have involved stimulants, emblematic of a worrying trend known as the "fourth wave" of overdoses. This complicates public health efforts and highlights the urgency needed to address the evolving crisis surrounding drug use and overdose fatalities.
Heroin Co-Use on the Rise
One of the most concerning revelations from the report is the significant rise in heroin use among those who also use fentanyl. Across the nation, heroin co-use surged nearly 18% from one year to the next, marking the first substantial increase observed in almost a decade. The heroin detection rate has notably increased and even surpassed 30% in the latter half of 2024.
The Outlook from Experts in the Field
Angela G. Huskey, Senior Vice President and Chief Clinical Officer at Millennium Health, expressed her concern: “While fentanyl use is falling, the rise in heroin co-use and the continuing increases in stimulant co-use create a dangerously unpredictable illicit drug supply.” The potential increase in the use of even more potent opioids poses an even greater threat to public safety.
Regional Variances in Substance Use
The report also presents compelling regional differences in drug use patterns. For instance, methamphetamine use was reported at over 78% among fentanyl users in certain regions, with the Northeast showing a higher prevalence of cocaine co-use. Meanwhile, heroin co-detection among individuals who tested positive for fentanyl peaked in the Midwest and South.
Methodology Behind the Data
Detailed in the Millennium Health Signals Report titled “Shifting Tides: The Continued Evolution of the ‘Fourth Wave’ of America’s Overdose Crisis,” the methodology involved thorough data collection. The report analyzed urine drug testing specimens from patients diagnosed with substance use disorders, involving a comprehensive sample across all states.
Understanding the Stakes Behind the Numbers
CEO Scott Walton emphasized the report's human aspect, urging stakeholders to consider the real-life impact of these statistics. “Behind the numbers are hundreds of thousands of individuals and families experiencing the pain associated with substance use disorders and overdoses. Our focus must remain on these people as we work to combat this continuing crisis.”
Frequently Asked Questions
What does the decline in fentanyl use indicate?
The decline suggests a potential shift in drug use trends, but it also raises concerns about rising heroin and methamphetamine use among those previously using fentanyl.
What are the implications of increased heroin co-use?
The rise in heroin co-use poses serious public health risks, suggesting a need for updated strategies to address substance use disorders effectively.
How is the drug crisis evolving in the U.S.?
The drug crisis is evolving to include a mix of substances where fentanyl use is declining while heroin and methamphetamine use is increasing significantly.
What is the “fourth wave” of overdose crisis?
The “fourth wave” refers to the increasing involvement of stimulants in fentanyl overdoses, complicating the landscape of substance use and recovery efforts.
How can data from the Millennium Health report be used?
The data can assist clinicians, researchers, and policymakers in developing informed strategies to tackle the ongoing drug overdose crisis effectively.
